Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,618 | -26,089 | -21,123 | -38,842 | -48,054 |
| Depreciation Amortization | 26 | 54 | 70 | 206 | 161 |
| Accounts payable and accrued liabilities | 1,663 | 106 | 424 | -2,185 | 1,583 |
| Other Working Capital | 452 | 437 | 135 | -2,076 | 976 |
| Other Operating Activity | -206 | 1,521 | 1,366 | 5,584 | 2,806 |
| Operating Cash Flow | $-26,683 | $-23,971 | $-19,128 | $-37,313 | $-42,528 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 7,174 | 16,615 | -23,933 |
| PPE Investments | -17 | -6 | -5 | -66 | -118 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -120 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -120 |
| Investing Cash Flow | $-17 | $-6 | $7,169 | $16,549 | $-24,171 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5,939 | 12,714 | 18,519 | 20,498 | 47,694 |
| Other Financing Activity | 6,980 | 10,825 | 0 | 0 | 0 |
| Financing Cash Flow | $12,919 | $23,539 | $18,519 | $20,498 | $47,694 |
| Exchange Rate Effect | -4 | -13 | -5 | -11 | -4 |
| Beginning Cash Position | 25,134 | 25,585 | 19,030 | 19,307 | 38,184 |
| End Cash Position | 11,349 | 25,134 | 25,585 | 19,030 | 19,175 |
| Net Cash Flow | $-13,785 | $-451 | $6,555 | $-277 | $-19,009 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,683 | -23,971 | -19,128 | -37,313 | -42,528 |
| Capital Expenditure | -17 | -6 | -5 | -66 | -118 |
| Free Cash Flow | -26,700 | -23,977 | -19,133 | -37,379 | -42,646 |